Stockreport

Spruce Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]

Spruce Biosciences, Inc.  (SPRB) 
PDF All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue missed analyst estimates by 42%. Earnings per share (EPS) exceeded analyst est [Read more]